scAAV9.U1a.hSGSH

· Ultragenyx Pharmaceutical Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for scAAV9.U1a.hSGSH, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH [Phase 2, Phase 3]